FATE THERAPEUTICS INC Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- FATE THERAPEUTICS INC stock issued during period, value, issued for services for the quarter ending 2018-09-30 was $1.25M.
- FATE THERAPEUTICS INC stock issued during period, value, issued for services for the quarter ending 2018-06-30 was $4.84M.
- FATE THERAPEUTICS INC stock issued during period, value, issued for services for fiscal 2018 was $6.10M.
- FATE THERAPEUTICS INC stock issued during period, value, issued for services for fiscal 2014 was $375.00K.
- FATE THERAPEUTICS INC stock issued during period, value, issued for services for fiscal 2008 was $18.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2018-12-31 | $6.10M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $1.25M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $4.84M 10-Q · filed 2018-11-01 | |
| 2014-12-31 | $375.00K 10-K · filed 2017-03-16 | |
| 2008-12-31 | $18.00K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |